Minnesota's medical cannabis program has been running since 2014, and the arrival of recreational legalization in 2023 created a need to update how the two systems work together. HF1672, introduced by Rep. Liz Reyer with co-author Rep. Zack Stephenson, is a broad update bill that tackles several areas of the medical program that need modernization. The bill modifies qualifying conditions, adjusts patient access rules, and addresses gaps that emerged as the recreational market came online.

Among the key changes, the bill updates the list of conditions that qualify a patient for medical cannabis, adjusts how medical cannabis businesses interact with the broader licensing framework, and clarifies patient protections that were left ambiguous in the original legalization law. It also addresses practical issues like how medical patients register, what products are available to them, and how the Office of Cannabis Management oversees the medical side of the market.

This bill matters most to the roughly 40,000 patients currently enrolled in Minnesota's medical cannabis program, as well as healthcare providers who certify patients and the businesses that serve them. As recreational dispensaries begin opening across the state, medical patients want assurance that their program will not be sidelined or absorbed into the recreational system in ways that reduce their access to specialized products and protections.